Abstract
Background: Coronavirus infection disease 2019 (COVID-19) is a disease caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), which has rapidly spread worldwide in December 2019. Besides the symptoms of acute respiratory distress and multiorgan failure, the cardiac involvement with acute myocardial injury is also a possible clinical scenario(1) Despite the initial opinion that high troponin levels increase mortality in patients, it is clear today that abnormal troponin are not necessarily a sign of acute myocarditis. The aim of this presentation is to show the diagnostic process for the occurrence of myocarditis in Covid-19 infection compared to the diagnostic process for myocarditis with other viruses called cardiotropic viruses.
The presentation refers mainly to the desire for paediatric cardiologists to learn about the fundamental difference in the approach to a child with SARS-CoV-2 compared to myocarditis of another etiolgy. From daily practice, it seems that with Covid-19 infection, more attention is paid to possible damage to the myocardium (due to elevated troponin levels), and too little attention is paid to other symptoms. This primarily refers to coagulation disorders that can develop diffuse intravascular coagulopathy as circulus vitiosus with tragic consequences.
This presentation is the experience from the perspective of paediatric cardiologists and has no basis for statistical analysis. It is aimed at the need for scientific research into the causes and consequences of various changes in the heart musculature caused by Covod-19 infection (most often in the context of multisystem inflammatory syndrome) in relation to extensive changes in the heart musculature in the case of infection with cardiotropic viruses.(2,3)